BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3669053)

  • 1. Quantitative cell-adhesion assay for Clostridium difficile cytotoxin.
    Mayall BC; Edmonds C; Griffin GE
    J Med Microbiol; 1987 Nov; 24(3):197-203. PubMed ID: 3669053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Clostridium difficile cytotoxin in HEp-2 and CHO cell lines.
    Murray PR; Weber CJ
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):331-3. PubMed ID: 6667607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and release of toxins A and B by Clostridium difficile.
    Ketley JM; Haslam SC; Mitchell TJ; Stephen J; Candy DC; Burdon DW
    J Med Microbiol; 1984 Dec; 18(3):385-91. PubMed ID: 6389875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile in Crohn's disease.
    Wright JM; Adams SP; Gribble MJ; Bowie WR
    Can J Surg; 1984 Sep; 27(5):435-7. PubMed ID: 6478320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile and its cytotoxin in hospitalized children with acute diarrhea.
    Niyogi SK; Dutta P; Dutta D; Mitra U; Sikdar S
    Indian Pediatr; 1991 Oct; 28(10):1129-32. PubMed ID: 1797664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.
    Vesely DL; Straub KD; Nolan CM; Rolfe RD; Finegold SM; Monson TP
    Infect Immun; 1981 Jul; 33(1):285-91. PubMed ID: 6114928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and some properties of cytotoxin produced by Clostridium difficile.
    Katoh T; Honda T; Miwatani T
    Microbiol Immunol; 1988; 32(6):551-64. PubMed ID: 3173147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two toxins produced by Clostridium difficile.
    Taylor NS; Thorne GM; Bartlett JG
    Infect Immun; 1981 Dec; 34(3):1036-43. PubMed ID: 7333662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoea disease.
    Schué V; Green GA; Monteil H
    J Med Microbiol; 1994 Nov; 41(5):316-8. PubMed ID: 7966202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxin A of Clostridium difficile is a potent cytotoxin.
    Tucker KD; Carrig PE; Wilkins TD
    J Clin Microbiol; 1990 May; 28(5):869-71. PubMed ID: 2112562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
    Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
    J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feacal carriage of cytotoxigenic strains of Clostridium difficile by adult Nigerians.
    Rotimi VO; Akindutire D
    East Afr Med J; 1989 May; 66(5):319-23. PubMed ID: 2791928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cytotoxin production and sporulation in Clostridium difficile.
    Kamiya S; Ogura H; Meng XQ; Nakamura S
    J Med Microbiol; 1992 Sep; 37(3):206-10. PubMed ID: 1518037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counterimmunoelectrophoresis vs. cytotoxicity assay for the detection of Clostridium difficile toxin.
    Levine HG; Kennedy M; LaMont JT
    J Infect Dis; 1982 Mar; 145(3):398. PubMed ID: 7061887
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromatographic separation and characterization of Pasteurella haemolytica cytotoxin.
    Mosier DA; Lessley BA; Confer AW; Antone SM; Gentry MJ
    Am J Vet Res; 1986 Oct; 47(10):2233-41. PubMed ID: 3096174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of 2-phosphoglycerate by cytotoxin B of Clostridium difficile.
    Knoop F; Martig R; Owens M
    FEBS Lett; 1990 Jul; 267(1):9-12. PubMed ID: 2365093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile culture-positive toxin-negative diarrhea.
    Lashner BA; Todorczuk J; Sahm DF; Hanauer SB
    Am J Gastroenterol; 1986 Oct; 81(10):940-3. PubMed ID: 3766495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the cytotoxin of Clostridium difficile on cultured hepatoma cells.
    Rihn B; Beck G; Monteil H; Lecerf F; Girardot R
    Biol Cell; 1985; 53(1):23-32. PubMed ID: 2581643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.